Chimera Bioengineering
1 known investors
Chimera develops engineered cell therapies for cancer that produce therapeutic proteins only upon encountering tumor cells, using natural biological control mechanisms to improve safety and efficacy. The company focuses on treating solid tumors and other currently incurable cancers through localized, controlled immune cell activation.
Investors · 1
Frequently asked questions
- What does Chimera Bioengineering do?
- Chimera develops engineered cell therapies for cancer that produce therapeutic proteins only upon encountering tumor cells, using natural biological control mechanisms to improve safety and efficacy. The company focuses on treating solid tumors and other currently incurable cancers through localized, controlled immune cell activation.
- Who are Chimera Bioengineering's investors?
- Chimera Bioengineering's investors include ShangBay Capital LLC.